← Open Payments lookup

EILEEN STARBRANCH: Open Payments

NPI 1982671590 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,312 in 12 payments from 7 companies in 2025. Trend: 2023 $1,145 · 2024 $1,480 · 2025 $1,312

Food & beverage: $1,312
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.3$328
Otsuka America Pharmaceutical, Inc.2$251
Luye Pharma (USA) Ltd.2$215
E.R. Squibb & Sons, L.L.C.2$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$109
Noven Therapeutics, LLC1$107
Axsome Therapeutics, Inc.1$101

Products named: UZEDY, ERZOFRI EXTENDED-RELEASE, COBENFY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, CAPLYTA, Xelstrym, Auvelity.

Industry payments across TX — which companies pay providers there.